High-throughput scaffold-free microtissues through 3D printing.
BACKGROUND
Three-dimensional (3D) cell cultures and 3D bioprinting have recently gained attention based on their multiple advantages over two-dimensional (2D) cell cultures, which have less translational potential to recapitulate human physiology. 3D scaffold supports, cell aggregate systems and hydrogels have been shown to accurately mimic native tissues and support more relevant cell-cell interactions for studying effects of drugs and bioactive agents on cells in 3D. The development of cost-effective, high-throughput and scaffold-free microtissue assays remains challenging. In the present study, consumer grade 3D printing was examined as a fabrication method for creation of high-throughput scaffold-free 3D spheroidal microtissues.


RESULTS
Consumer grade 3D printing was capable of forming 96-well cell culture inserts to create scaffold-free microtissues in liquid suspensions. The inserts were seeded with human glioblastoma, placental-derived mesenchymal stem cells, and intestinal smooth muscle cells. These inserts allowed for consistent formation of cell density-controllable microtissues that permit screening of bioactive agents.


CONCLUSION
A variety of different cell types, co-cultures, and drugs may be evaluated with this 3D printed microtissue insert. It is suggested that the microtissue inserts may benefit 3D cell culture researchers as an economical assay solution with applications in pharmaceuticals, disease modeling, and tissue-engineering.
['Boyer|Christen J|CJ|', 'Ballard|David H|DH|http://orcid.org/0000-0001-7470-3364', 'Barzegar|Mansoureh|M|', 'Winny Yun|J|J|', 'Woerner|Jennifer E|JE|', 'Ghali|Ghali E|GE|', 'Boktor|Moheb|M|', 'Wang|Yuping|Y|', 'Steven Alexander|J|J|']
Microtissues 3D printing Spheroids Screening